peptide t has been researched along with AIDS Seroconversion in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenneman, DE; Buzy, J; Martin, A; Pert, CB; Ruff, MR; Salazar, A | 1 |
| Dhiver, C; Gastaut, JA; Mawas, C; Olive, D; Poizot-Martin, I | 1 |
| Lazega, D; Marcusson, JA; Pert, CB; Ruff, MR; Sundquist, KG; Wetterberg, L | 1 |
1 trial(s) available for peptide t and AIDS Seroconversion
| Article | Year |
|---|---|
Analyses of peptide T efficacy on neuropsychological performance.
Topics: Double-Blind Method; HIV Seropositivity; Humans; Mental Processes; Peptide T; Prospective Studies; Psychomotor Performance | 1996 |
3 other study(ies) available for peptide t and AIDS Seroconversion
| Article | Year |
|---|---|
Potent gp120-like neurotoxic activity in the cerebrospinal fluid of HIV-infected individuals is blocked by peptide T.
Topics: Animals; Cell Survival; Cells, Cultured; Cerebrospinal Fluid Proteins; HIV Envelope Protein gp120; HIV Seropositivity; HIV-1; Humans; Mice; Mice, Inbred C57BL; Neurons; Peptide T; Prospective Studies | 1992 |
Are CD4 antibodies and peptide T new treatments for psoriasis?
Topics: Adult; Antibodies, Monoclonal; CD4 Antigens; HIV Seropositivity; HIV-1; Humans; Male; Peptide T; Psoriasis | 1991 |
Peptide T and psoriasis.
Topics: Adult; Biopsy; HIV Seropositivity; Humans; Infusions, Intravenous; Male; Peptide T; Psoriasis; Time Factors | 1989 |